ESR1 and breast cancer: Changes in IL-10 signaling and expression of chemokine receptors were observed after exposure to secreted factors from TNBC cells compared to the ER+ MCF-7 cells, suggesting that this is a specific effect of the TNBC subtype of breast cancer.